Pathway Financial Advisers’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
4,252
+6
+0.1% +$3.46K 0.55% 66
2026
Q1
$2.9M Buy
4,246
+280
+7% +$194K 0.82% 44
2025
Q4
$2.26M Sell
3,966
-5
-0.1% -$2.9K 0.66% 55
2025
Q3
$2.38M Buy
3,971
+149
+4% +$84.5K 0.69% 47
2025
Q2
$1.91M Buy
3,822
+24
+0.6% +$11.8K 0.62% 60
2025
Q1
$1.94M Buy
3,798
+416
+12% +$199K 0.67% 54
2024
Q4
$1.59M Buy
3,382
+76
+2% +$38.2K 0.53% 62
2024
Q3
$1.75M Sell
3,306
-47
-1% -$23K 0.79% 41
2024
Q2
$1.44M Sell
3,353
-36
-1% -$16.4K 0.52% 65
2024
Q1
$1.62M Sell
3,389
-181
-5% -$83.3K 0.58% 62
2023
Q4
$1.67M Sell
3,570
-27
-0.8% -$12.7K 0.64% 57
2023
Q3
$1.58M Buy
+3,597
New +$1.58M 0.65% 56
2023
Q1
$2.18M Sell
4,726
-1,329
-22% -$617K 0.88% 37
2022
Q4
$3.3M Buy
+6,055
New +$3.16M 1.34% 18

Other funds holding NOC

Pathway Financial Advisers's NOC Position: Q2 2026 in Review

Pathway Financial Advisers increased its Northrop Grumman (NOC) stake by 0.14% in Q2 2026, buying an estimated $3.46K and bringing the position to 4,252 shares worth $2.17M. The position accounts for 0.55% of the portfolio, ranked #66.

Pathway Financial Advisers first reported a position in NOC in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.3M in Q4 2022. 815 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Pathway Financial Advisers held 4,252 shares of Northrop Grumman worth $2.17M as of Q2 2026.
  • Pathway Financial Advisers bought 6 Northrop Grumman shares in Q2 2026, an estimated $3.46K.
  • Northrop Grumman made up 0.55% of Pathway Financial Advisers's portfolio in Q2 2026, its #66 holding.
  • Pathway Financial Advisers first reported a position in Northrop Grumman in Q4 2022 and has held it in 14 quarters since.
  • Pathway Financial Advisers's Northrop Grumman position peaked at $3.3M in Q4 2022.
  • 815 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.